Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt · Delayed Price · Currency is EGP

365.00

+18.49 (5.34%)

At close: Oct 4, 2026

Market Cap	7.88B +129.5%
Revenue (ttm)	1.68B +36.2%
Net Income	518.98M +37.8%
EPS	22.81 -65.9%
Shares Out	22.75M
PE Ratio	15.19
Forward PE	n/a
Dividend	13.19 (3.61%)
Ex-Dividend Date	Oct 27, 2025

Volume	428,824
Open	346.51
Previous Close	346.51
Day's Range	350.02 - 369.50
52-Week Range	130.00 - 490.86
Beta	0.16
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, central nervous system, dermatological, cardiovascular diseases, vitamins and minerals, analgesics and antipyretics, respiratory system, and gastrointestinal and metabolic disorders. It also provides products for anthelmintic, anti-hypertensi... [Read more]

Industry Pharmaceutical Preparations

Founded 1940

Employees 144

Stock Exchange Egyptian Stock Exchange

Ticker Symbol MPCI

Full Company Profile

Financial Performance

In fiscal year 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.

Financial Statements